Skip to content

Bioventus Inc.

BVS· NasdaqCore metricsCIK 1665988

Surgical & medical instruments & apparatus143 peers

Last sale
Nov 12, 2026 · -1.09%
Market cap
$916.34M
84.26M shares
Filings
464
$142.44M
Q3 2026−0.9% FY25 yoy
$5.99M
Q3 2026N/M FY25 yoy
$9.70M
Q3 2026N/M FY25 yoy
$47.60M
Q3 2026derived+90.8% FY25 yoy
$0.08
Q3 2026N/M FY25 yoy
$30.71M
Q3 2026+23.2% FY25 yoy
$916.34M
16.0×
1.6×
3.8×
9.27%
—

Twelve months to Sep 26, 2026 · derived

Price

$10.88+41.23%+$3.18past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$568.09MFY 2025
$573.28M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$568,087,000reported
FY 20242024-12-31$573,280,000reported
FY 20232023-12-31$512,345,000reported
FY 20222022-12-31$512,117,000reported
FY 20212021-12-31$430,898,000reported
FY 20202020-12-31$321,161,000reported
FY 20192019-12-31$340,141,000reported

Segments

Revenue by Segments, FY2022 to FY2025FY2022U.S. · FY2022 · $455.25MInternational · FY2022 · $56.87MFY2023U.S. · FY2023 · $449.86MInternational · FY2023 · $62.49MFY2024U.S. · FY2024 · $506.81MInternational · FY2024 · $66.47MFY2025U.S. · FY2025 · $502.10MInternational · FY2025 · $65.99M
LineFY2025ShareChange
U.S.$502.10M88%−0.9%
International$65.99M12%−0.7%
Total$568.09M

From the 10-K filed Mar 5, 2026BVS

Surgical & medical instruments & apparatus

Bioventus Inc. is the 28th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Bioventus Inc. · CIK 1665988 · Engraved from SEC EDGAR